Delivery Order SPE2DB24D2215-SPE2DB25FGTAC
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Eliquis 5 mg tablets (60-count units) with a ceiling value of $25,763.39. This is a firm fixed price delivery order with an ultimate completion date of July 25, 2025, and represents a competitively awarded contract with no set-aside designation. The order will be fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania, the company's corporate headquarters....
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) with a ceiling value of $18,978.90. This non-set-aside competitive award is scheduled for completion by August 8, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under the company's...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of Eliquis 5 mg tablets (60-count packaging) valued at $12,260.04. This is a firm fixed-price delivery order with no set-aside designation, executed under competitive procedures. The order is scheduled for completion by May 13, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Eliquis is an anticoagulant...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) valued at $27,727.45. The contract represents a firm fixed-price delivery order with an ultimate completion date of September 18, 2025, and was competitively awarded without set-aside provisions. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Eliquis 5 mg tablets (60-count units) with a ceiling value of $11,793.60. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is to be completed by July 31, 2025, with performance executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order operates...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of 60 tablets of Eliquis 5 mg at a ceiling value of $6,658.35. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is scheduled for completion by September 8, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Eliquis 5 mg tablets in a 60-count package. This contract, valued at $16,478.31, is a firm fixed-price delivery order with an ultimate completion date of August 19, 2025. The award carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) valued at $2,343.12. This is a firm fixed-price delivery order with an ultimate completion date of August 25, 2025, and represents performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting open competition in federal...
- The Defense Logistics Agency awarded a $36,587.93 delivery order to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on July 28, 2025, with completion scheduled for July 29, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contractor, headquartered in Conshohocken, Pennsylvania, will perform all work...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 11, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) valued at $9,066.65. This firm fixed-price delivery order, with an ultimate completion date of June 12, 2025, represents a non-set-aside competitive award and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. Eliquis is a widely prescribed anticoagulant medication used in military and veteran...
- SPE2DB24D2215Indefinite Delivery Contract
- SPE2DB24D2215-SPE2DB25FGTACDelivery Order
The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on June 20, 2025, for the supply of Eliquis 5 mg tablets (60-count) with a contract value of $8,899.62. This is a firm fixed-price delivery order with an ultimate completion date of June 23, 2025, and represents work performed at the contractor's Conshohocken, Pennsylvania location. The contract was competitively awarded with no set-aside designation. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026 that provides comprehensive global pharmaceutical support to military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical procurement vendor for military and veteran healthcare systems, supplying brand-name and generic medications across multiple therapeutic domains. The Eliquis order fulfills pharmaceutical supply needs for Defense Health Agency customers and other federal healthcare systems operating under the DLA's medical supply chain framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.9k | 6/20/25 |